CDC and FDA will continue to be in close contact with manufacturers to ensure the availability of additional doses through end of this year and for early 2024 to meet the demand...

Updated WHO guidelines.

New study.

A total of 290 U.S. patients participated in the vitamin C domain at UPMC, the Ohio State University Wexner Medical Center, and Oregon Health & Science University.

NIH-supported research finds key differences between children & adults with COVID-19.

HHS and Pfizer will begin preparations for Pfizer to transition Paxlovid to the commercial market in November 2023.

Today, wild poliovirus remains endemic in just two countries – Pakistan and Afghanistan – and 80% of variant poliovirus cases are found in just four subnational regions.

A person’s immune response to variants of SARS-CoV-2, the virus that causes COVID-19, depends on their previous exposure.

Formulated to better protect against currently circulating variants.

WHO recommendations.